city hospitals independent commercial enterprises limited
city hospitals independent commercial enterprises limited Company Information
Company Number
08808703
Next Accounts
Dec 2025
Shareholders
south tyneside & sunderland nhs foundation trust
Group Structure
View All
Industry
Hospital activities
Registered Address
sunderland royal hospital, kayll road, sunderland, tyne & wear, SR4 7TP
Website
choicesunderland.co.ukcity hospitals independent commercial enterprises limited Estimated Valuation
Pomanda estimates the enterprise value of CITY HOSPITALS INDEPENDENT COMMERCIAL ENTERPRISES LIMITED at £106.9m based on a Turnover of £124.5m and 0.86x industry multiple (adjusted for size and gross margin).
city hospitals independent commercial enterprises limited Estimated Valuation
Pomanda estimates the enterprise value of CITY HOSPITALS INDEPENDENT COMMERCIAL ENTERPRISES LIMITED at £26.2m based on an EBITDA of £4.4m and a 5.95x industry multiple (adjusted for size and gross margin).
city hospitals independent commercial enterprises limited Estimated Valuation
Pomanda estimates the enterprise value of CITY HOSPITALS INDEPENDENT COMMERCIAL ENTERPRISES LIMITED at £93m based on Net Assets of £36.8m and 2.53x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
City Hospitals Independent Commercial Enterprises Limited Overview
City Hospitals Independent Commercial Enterprises Limited is a live company located in sunderland, SR4 7TP with a Companies House number of 08808703. It operates in the hospital activities sector, SIC Code 86101. Founded in December 2013, it's largest shareholder is south tyneside & sunderland nhs foundation trust with a 100% stake. City Hospitals Independent Commercial Enterprises Limited is a established, mega sized company, Pomanda has estimated its turnover at £124.5m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
City Hospitals Independent Commercial Enterprises Limited Health Check
Pomanda's financial health check has awarded City Hospitals Independent Commercial Enterprises Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
5 Weak
Size
annual sales of £124.5m, make it larger than the average company (£4.7m)
£124.5m - City Hospitals Independent Commercial Enterprises Limited
£4.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 19%, show it is growing at a faster rate (8%)
19% - City Hospitals Independent Commercial Enterprises Limited
8% - Industry AVG
Production
with a gross margin of 14.8%, this company has a higher cost of product (34.8%)
14.8% - City Hospitals Independent Commercial Enterprises Limited
34.8% - Industry AVG
Profitability
an operating margin of 3.4% make it less profitable than the average company (9.9%)
3.4% - City Hospitals Independent Commercial Enterprises Limited
9.9% - Industry AVG
Employees
with 762 employees, this is above the industry average (56)
762 - City Hospitals Independent Commercial Enterprises Limited
56 - Industry AVG
Pay Structure
on an average salary of £36.8k, the company has an equivalent pay structure (£33.9k)
£36.8k - City Hospitals Independent Commercial Enterprises Limited
£33.9k - Industry AVG
Efficiency
resulting in sales per employee of £163.4k, this is more efficient (£75.7k)
£163.4k - City Hospitals Independent Commercial Enterprises Limited
£75.7k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (21 days)
0 days - City Hospitals Independent Commercial Enterprises Limited
21 days - Industry AVG
Creditor Days
its suppliers are paid after 26 days, this is quicker than average (31 days)
26 days - City Hospitals Independent Commercial Enterprises Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 15 days, this is more than average (12 days)
15 days - City Hospitals Independent Commercial Enterprises Limited
12 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 40 weeks, this is average cash available to meet short term requirements (42 weeks)
40 weeks - City Hospitals Independent Commercial Enterprises Limited
42 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 54.6%, this is a higher level of debt than the average (41.6%)
54.6% - City Hospitals Independent Commercial Enterprises Limited
41.6% - Industry AVG
CITY HOSPITALS INDEPENDENT COMMERCIAL ENTERPRISES LIMITED financials
City Hospitals Independent Commercial Enterprises Limited's latest turnover from March 2024 is £124.5 million and the company has net assets of £36.8 million. According to their latest financial statements, City Hospitals Independent Commercial Enterprises Limited has 762 employees and maintains cash reserves of £17.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 124,529,000 | 99,540,000 | 81,278,000 | 73,546,885 | 72,751,652 | 59,887,245 | 40,718,274 | 9,930,630 | 4,817,138 | 4,545,220 |
| Other Income Or Grants | ||||||||||
| Cost Of Sales | 106,045,000 | 84,597,000 | 66,235,000 | 3,808,493 | ||||||
| Gross Profit | 18,484,000 | 14,943,000 | 15,043,000 | 736,727 | ||||||
| Admin Expenses | 14,302,000 | 11,795,000 | 10,996,000 | 809,822 | ||||||
| Operating Profit | 4,182,000 | 3,148,000 | 4,047,000 | 3,803,980 | 4,340,912 | 4,222,731 | 2,774,666 | 505,438 | 251,936 | -73,095 |
| Interest Payable | 1,022,000 | 467,000 | 672,000 | 1,018,411 | 1,201,258 | 1,232,310 | 1,454,629 | 253,877 | 25,332 | |
| Interest Receivable | 1,034,000 | 492,000 | 615,000 | 159,969 | 178,986 | 199,129 | 218,748 | 35,361 | 6 | |
| Pre-Tax Profit | 4,194,000 | 3,173,000 | 3,990,000 | 2,945,538 | 3,318,640 | 3,189,551 | 1,538,785 | 286,922 | 226,610 | -73,095 |
| Tax | -1,074,000 | -994,000 | -739,000 | -586,960 | -380,357 | -621,762 | -302,348 | -58,448 | -42,300 | -10,443 |
| Profit After Tax | 3,120,000 | 2,179,000 | 3,251,000 | 2,358,578 | 2,938,283 | 2,567,789 | 1,236,437 | 228,474 | 184,310 | -83,538 |
| Dividends Paid | ||||||||||
| Retained Profit | 3,120,000 | 2,179,000 | 3,251,000 | 2,358,578 | 2,938,283 | 2,567,789 | 1,236,437 | 228,474 | 184,310 | -83,538 |
| Employee Costs | 28,046,000 | 19,981,000 | 17,898,000 | 17,325,246 | 15,143,307 | 13,982,340 | 7,855,877 | 1,318,635 | 135,871 | 27,105 |
| Number Of Employees | 762 | 539 | 526 | 659 | 653 | 634 | 633 | 307 | ||
| EBITDA* | 4,411,000 | 3,272,000 | 4,133,000 | 3,880,968 | 4,400,233 | 4,225,879 | 2,795,314 | 508,586 | 254,365 | -72,240 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,655,000 | 1,108,000 | 1,072,000 | 942,624 | 875,189 | 856,212 | 3,160 | 5,107 | 7,055 | 8,884 |
| Intangible Assets | 195,000 | 292,000 | 602 | 1,800 | 3,000 | 4,200 | 5,400 | 6,000 | ||
| Investments & Other | 200,000 | 200,000 | 200,000 | 200,000 | 15,373 | |||||
| Debtors (Due After 1 year) | 30,704,000 | 14,531,000 | 19,059,000 | 32,554,778 | 38,120,503 | 27,272,847 | 31,236,019 | 35,127,774 | ||
| Total Fixed Assets | 32,754,000 | 16,131,000 | 20,331,000 | 33,697,402 | 38,996,294 | 28,130,859 | 31,242,179 | 35,152,454 | 12,455 | 14,884 |
| Stock & work in progress | 4,437,000 | 2,794,000 | 2,840,000 | 2,512,951 | 2,407,100 | 2,126,962 | 1,837,782 | 854,291 | 578,300 | 683,820 |
| Trade Debtors | 20,000 | 33,000 | 133,000 | 214,942 | 511,387 | 8,139,881 | 1,155,155 | 967,906 | ||
| Group Debtors | 18,849,000 | 23,144,000 | 4,802,000 | 6,802,621 | 14,198,806 | 4,220,409 | 1,018,211 | 1,150,836 | 512,204 | 534,809 |
| Misc Debtors | 7,586,000 | 5,085,000 | 6,238,000 | 7,494,737 | 8,105,230 | 4,274,633 | 4,122,377 | 9,805,000 | 223,349 | 143,229 |
| Cash | 17,277,000 | 7,174,000 | 13,099,000 | 6,505,303 | 2,260,151 | 2,194,022 | 4,569,509 | 3,002,795 | 496,589 | 100,915 |
| misc current assets | ||||||||||
| total current assets | 48,169,000 | 38,230,000 | 27,112,000 | 23,530,554 | 27,482,674 | 20,955,907 | 12,703,034 | 15,780,828 | 1,810,442 | 1,462,773 |
| total assets | 80,923,000 | 54,361,000 | 47,443,000 | 57,227,956 | 66,478,968 | 49,086,766 | 43,945,213 | 50,933,282 | 1,822,897 | 1,477,657 |
| Bank overdraft | ||||||||||
| Bank loan | ||||||||||
| Trade Creditors | 7,721,000 | 4,514,000 | 4,738,000 | 3,502,259 | 6,550,944 | 17,428,085 | 10,812,234 | 8,294,016 | 357,490 | 237,257 |
| Group/Directors Accounts | 3,132,000 | 2,462,000 | 1,496,000 | 3,887,999 | 7,473,415 | 4,298,250 | 100,000 | 100,000 | ||
| other short term finances | ||||||||||
| hp & lease commitments | 1,695,000 | 1,406,000 | 1,671,000 | 2,096,768 | 2,532,486 | |||||
| other current liabilities | 9,854,000 | 11,079,000 | 4,772,000 | 5,043,756 | 4,566,860 | 2,223,264 | 462,392 | 320,960 | ||
| total current liabilities | 22,402,000 | 19,461,000 | 12,677,000 | 14,530,782 | 21,123,705 | 17,428,085 | 10,812,234 | 14,815,530 | 919,882 | 658,217 |
| loans | 16,382,000 | 4,706,000 | 6,275,000 | 7,771,377 | 11,552,886 | 15,537,569 | 19,666,176 | 23,895,978 | 800,000 | 900,000 |
| hp & lease commitments | 5,358,000 | 3,221,000 | 3,753,000 | 13,462,696 | 14,729,010 | |||||
| Accruals and Deferred Income | ||||||||||
| other liabilities | ||||||||||
| provisions | 11,614 | 10,110 | 8,590 | 2,242 | 2,977 | |||||
| total long term liabilities | 21,740,000 | 7,927,000 | 10,028,000 | 21,234,073 | 26,293,510 | 15,547,679 | 19,674,766 | 23,895,978 | 802,242 | 902,977 |
| total liabilities | 44,142,000 | 27,388,000 | 22,705,000 | 35,764,855 | 47,417,215 | 32,975,764 | 30,487,000 | 38,711,508 | 1,722,124 | 1,561,194 |
| net assets | 36,781,000 | 26,973,000 | 24,738,000 | 21,463,101 | 19,061,753 | 16,111,002 | 13,458,213 | 12,221,774 | 100,773 | -83,537 |
| total shareholders funds | 36,781,000 | 26,973,000 | 24,738,000 | 21,463,101 | 19,061,753 | 16,111,002 | 13,458,213 | 12,221,774 | 100,773 | -83,537 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | 4,182,000 | 3,148,000 | 4,047,000 | 3,803,980 | 4,340,912 | 4,222,731 | 2,774,666 | 505,438 | 251,936 | -73,095 |
| Depreciation | 229,000 | 124,000 | 86,000 | 76,386 | 58,123 | 1,948 | 19,448 | 1,948 | 2,429 | 855 |
| Amortisation | 602 | 1,198 | 1,200 | 1,200 | 1,200 | |||||
| Tax | -1,074,000 | -994,000 | -739,000 | -586,960 | -380,357 | -621,762 | -302,348 | -58,448 | -42,300 | -10,443 |
| Stock | 1,643,000 | -46,000 | 327,049 | 105,851 | 280,138 | 289,180 | 983,491 | 275,991 | -105,520 | 683,820 |
| Debtors | 14,366,000 | 12,561,000 | -16,835,078 | -13,868,848 | 17,028,156 | 6,376,008 | -9,519,754 | 46,315,963 | 57,515 | 678,038 |
| Creditors | 3,207,000 | -224,000 | 1,235,741 | -3,048,685 | -10,877,141 | 6,615,851 | 2,518,218 | 7,936,526 | 120,233 | 237,257 |
| Accruals and Deferred Income | -1,225,000 | 6,307,000 | -271,756 | 476,896 | 4,566,860 | -2,223,264 | 1,760,872 | 141,432 | 320,960 | |
| Deferred Taxes & Provisions | -11,614 | 1,504 | 1,520 | 8,590 | -2,242 | -735 | 2,977 | |||
| Cash flow from operations | -10,690,000 | -4,154,000 | 20,866,014 | 14,473,602 | -19,597,195 | 3,556,300 | 11,332,773 | -36,446,660 | 521,000 | -883,347 |
| Investing Activities | ||||||||||
| capital expenditure | -15,739 | |||||||||
| Change in Investments | 200,000 | -15,373 | 15,373 | |||||||
| cash flow from investments | -15,739 | |||||||||
| Financing Activities | ||||||||||
| Bank loans | ||||||||||
| Group/Directors Accounts | 670,000 | 966,000 | -2,391,999 | -3,585,416 | 7,473,415 | -4,298,250 | 4,198,250 | 100,000 | ||
| Other Short Term Loans | ||||||||||
| Long term loans | 11,676,000 | -1,569,000 | -1,496,377 | -3,781,509 | -3,984,683 | -4,128,607 | -4,229,802 | 23,095,978 | -100,000 | 900,000 |
| Hire Purchase and Lease Commitments | 2,426,000 | -797,000 | -10,135,464 | -1,702,032 | 17,261,496 | |||||
| other long term liabilities | ||||||||||
| share issue | ||||||||||
| interest | 12,000 | 25,000 | -57,000 | -858,442 | -1,022,272 | -1,033,181 | -1,235,881 | -218,516 | -25,326 | |
| cash flow from financing | 21,472,000 | -1,319,000 | -14,056,941 | -9,884,629 | 19,740,424 | -5,076,788 | -9,763,931 | 38,968,239 | -125,326 | 1,000,001 |
| cash and cash equivalents | ||||||||||
| cash | 10,103,000 | -5,925,000 | 6,593,697 | 4,245,152 | 66,129 | -2,375,487 | 1,566,714 | 2,506,206 | 395,674 | 100,915 |
| overdraft | ||||||||||
| change in cash | 10,103,000 | -5,925,000 | 6,593,697 | 4,245,152 | 66,129 | -2,375,487 | 1,566,714 | 2,506,206 | 395,674 | 100,915 |
city hospitals independent commercial enterprises limited Credit Report and Business Information
City Hospitals Independent Commercial Enterprises Limited Competitor Analysis
Perform a competitor analysis for city hospitals independent commercial enterprises limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mega companies, companies in SR4 area or any other competitors across 12 key performance metrics.
city hospitals independent commercial enterprises limited Ownership
CITY HOSPITALS INDEPENDENT COMMERCIAL ENTERPRISES LIMITED group structure
City Hospitals Independent Commercial Enterprises Limited has no subsidiary companies.
Ultimate parent company
SPREETAIL INTERNATIONAL HOLDINGS LLC
#0103719
1 parent
CITY HOSPITALS INDEPENDENT COMMERCIAL ENTERPRISES LIMITED
08808703
city hospitals independent commercial enterprises limited directors
City Hospitals Independent Commercial Enterprises Limited currently has 6 directors. The longest serving directors include Mr Mark Stouph (Jan 2015) and Mr Wayne Carr (Jan 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mark Stouph | United Kingdom | 57 years | Jan 2015 | - | Director |
| Mr Wayne Carr | 49 years | Jan 2017 | - | Director | |
| Mr Paul Farquhar | 63 years | Oct 2019 | - | Director | |
| Mrs Claire Povey | 44 years | Jan 2023 | - | Director | |
| Mr Peter Sutton | England | 49 years | Jan 2025 | - | Director |
| Mr Shaun Wayman | 50 years | Jan 2025 | - | Director |
P&L
March 2024turnover
124.5m
+25%
operating profit
4.2m
+33%
gross margin
14.9%
-1.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
36.8m
+0.36%
total assets
80.9m
+0.49%
cash
17.3m
+1.41%
net assets
Total assets minus all liabilities
city hospitals independent commercial enterprises limited company details
company number
08808703
Type
Private limited with Share Capital
industry
86101 - Hospital activities
incorporation date
December 2013
age
12
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
FORVIS MAZARS LLP
address
sunderland royal hospital, kayll road, sunderland, tyne & wear, SR4 7TP
Bank
LLOYDS TSB BANK PLC
Legal Advisor
-
city hospitals independent commercial enterprises limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to city hospitals independent commercial enterprises limited.
city hospitals independent commercial enterprises limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CITY HOSPITALS INDEPENDENT COMMERCIAL ENTERPRISES LIMITED. This can take several minutes, an email will notify you when this has completed.
city hospitals independent commercial enterprises limited Companies House Filings - See Documents
| date | description | view/download |
|---|
